ATE5716T1 - Dipeptid-derivate von 2-amin-1,2-desoxy-d-glucose und verfahren zur herstellung. - Google Patents

Dipeptid-derivate von 2-amin-1,2-desoxy-d-glucose und verfahren zur herstellung.

Info

Publication number
ATE5716T1
ATE5716T1 AT81400901T AT81400901T ATE5716T1 AT E5716 T1 ATE5716 T1 AT E5716T1 AT 81400901 T AT81400901 T AT 81400901T AT 81400901 T AT81400901 T AT 81400901T AT E5716 T1 ATE5716 T1 AT E5716T1
Authority
AT
Austria
Prior art keywords
desoxy
glucose
amine
manufacture
mdp
Prior art date
Application number
AT81400901T
Other languages
English (en)
Inventor
Philippe L. Durette
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Application granted granted Critical
Publication of ATE5716T1 publication Critical patent/ATE5716T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT81400901T 1980-06-09 1981-06-05 Dipeptid-derivate von 2-amin-1,2-desoxy-d-glucose und verfahren zur herstellung. ATE5716T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/157,906 US4315913A (en) 1980-06-09 1980-06-09 Immunologically active dipeptidyl 2-amino-1,2-dideoxy-D-glucose derivatives and methods of preparation
EP81400901A EP0041896B1 (de) 1980-06-09 1981-06-05 Dipeptid-Derivate von 2-Amin-1,2-desoxy-D-glucose und Verfahren zur Herstellung

Publications (1)

Publication Number Publication Date
ATE5716T1 true ATE5716T1 (de) 1984-01-15

Family

ID=22565821

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81400901T ATE5716T1 (de) 1980-06-09 1981-06-05 Dipeptid-derivate von 2-amin-1,2-desoxy-d-glucose und verfahren zur herstellung.

Country Status (10)

Country Link
US (1) US4315913A (de)
EP (1) EP0041896B1 (de)
JP (1) JPS5726698A (de)
AT (1) ATE5716T1 (de)
CA (1) CA1173430A (de)
DE (1) DE3161775D1 (de)
DK (1) DK246181A (de)
ES (1) ES8207512A1 (de)
GR (1) GR74573B (de)
PT (1) PT73126B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
ZA853989B (en) * 1984-05-29 1986-01-29 Ciba Geigy Ag Acylated sugar derivatives,processes for their manufacture,and their use
US4640911A (en) * 1985-05-29 1987-02-03 Ciba-Geigy Corporation Acylated sugar derivatives, processes for their manufacture, and their use
JPS61275299A (ja) * 1985-05-29 1986-12-05 Akira Hasegawa デオキシムラミルジペプチド誘導体
JPS61276873A (ja) * 1985-05-31 1986-12-06 Sony Chem Kk 導電異方性接着剤
US4868157A (en) * 1987-10-05 1989-09-19 Merck & Co., Inc. Dipeptidyl 2-amino-1,2-dideoxy-D-glucose derivatives as host resistance enhancers in AIDS-immunocompromised hosts and methods of use
US4895835A (en) * 1987-11-20 1990-01-23 Nisshin Oil Mills, Ltd. Muramyl peptide derivatives and use thereof
HU205147B (en) * 1989-06-29 1992-03-30 Sandoz Ag Process for producing muramyl dipeptide derivative and pharmaceutical compostions comprising same
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
AU2657495A (en) * 1994-05-23 1995-12-18 Research And Development Institute, Inc. Candida albicans adhesin as a vaccine
US6488929B2 (en) 1994-05-23 2002-12-03 Montana State University Candida albicans phosphomannan complex as a vaccine
US6309642B1 (en) 1997-04-28 2001-10-30 The Research And Development Institute, Inc. Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
US20030072775A1 (en) * 1997-04-28 2003-04-17 The Research And Development Institute Inc. Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
WO2017098529A1 (en) * 2015-12-10 2017-06-15 Bharat Biotech International Limited Novel muramyl peptide derivative compound, synthesis and uses thereof
US10576147B2 (en) 2015-12-15 2020-03-03 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2288527A2 (fr) 1974-10-22 1976-05-21 Anvar Compositions contenant de la n-acetyl-muramyl- l-alanyl - d-isoglutamine ou de l'acide n-acetyl-muramyl-l-alanyl - d-glutamique, exemptes d'huile et ayant des proprietes adjuvantes
US4082735A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
GB1563561A (en) * 1976-06-23 1980-03-26 Daiichi Seiyaku Co Muramyldipeptide derivatives and process for the preparation thereof
US4083736A (en) * 1977-03-09 1978-04-11 Seaquist Valve Company, Div. Of Pittway Corporation Filter mounting apparatus

Also Published As

Publication number Publication date
EP0041896B1 (de) 1983-12-28
DE3161775D1 (en) 1984-02-02
ES502856A0 (es) 1982-10-01
PT73126A (en) 1981-07-01
DK246181A (da) 1981-12-10
CA1173430A (en) 1984-08-28
EP0041896A1 (de) 1981-12-16
US4315913A (en) 1982-02-16
ES8207512A1 (es) 1982-10-01
GR74573B (de) 1984-06-29
PT73126B (en) 1985-12-20
JPS5726698A (en) 1982-02-12

Similar Documents

Publication Publication Date Title
ATE5716T1 (de) Dipeptid-derivate von 2-amin-1,2-desoxy-d-glucose und verfahren zur herstellung.
FI842992A0 (fi) Immunologiskt definitionsfoerfarande.
BE877926A (fr) Procede de determination immunologique d'anticorps specifiques d'une classe d'antigenes
NO870412L (no) Peptider.
BG37523A3 (en) Method for preparing peptides
ES515132A0 (es) "procedimiento para la determinacion de un antigeno carcinoembrionico".
IT8348094A0 (it) Antigene di picornavirus sintetico
IT1114209B (it) Determinazione di antigeni oppure di anticorpi
FI842215A (fi) Foerfarande foer framstaellning av levande effektiveringsvaccin och pao detta saett erhaollna vaccin.
IT1131966B (it) Metodo per la fabbricazione di un volano magnete e volano ottenuto
AT364718B (de) Verfahren zur herstellung neuer muramylpeptid antigen-konjugate
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
KR900005986A (ko) 항원용액중의 보조제로서 수산화아연 또는 수산화철의 용도, 및 이러한 보조제를 함유하는 항원용액
BG37838A3 (en) Method for preparing cephalosporines
IT1194744B (it) Sistema di avviamento di combustione
ES2236703T3 (es) Uso de metodos para identificar oligopeptidos de señal hidrofilos.
DK192890A (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
AR228806A1 (es) Procedimiento de preparacion de un antigeno toxoplasmico
FI922710A0 (fi) Eliminering av aktiverade lymfocyter.
ATE8394T1 (de) Verfahren zur herstellung chlorierter benzoxazolonderivate.
SU73939A1 (ru) Способ очистки и концентрации антитоксических лечебных сывороток
RU2001106408A (ru) Способ стимуляции образования антител при иммунизации лабораторных животных
IT1102949B (it) Dispositivo particolarmente adatto per l'illuminazione interna di borse o simili
ATE45500T1 (de) Verfahren zur herstellung von tuberkulin-l antigen.
PL267231A1 (en) Method of obtaining enzootic cattle leukaemia virus antigen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee